Theratechnologies Inc.
THTX
$2.77
-$0.05-1.77%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 101.48% | -355.68% | 213.17% | 122.03% | -62.65% |
| Total Depreciation and Amortization | -0.41% | 0.82% | -61.25% | 144.10% | -10.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -83.58% | 2,245.63% | 30.79% | -56.05% | -76.43% |
| Change in Net Operating Assets | -199.34% | -849.26% | 118.72% | -304.50% | 125.98% |
| Cash from Operations | -4,192.51% | -104.93% | 1,687.59% | 83.02% | 58.40% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4,256.02% | -78.69% | 668.61% | -202.24% | -5.63% |
| Cash from Investing | -4,257.83% | -78.69% | 668.61% | -202.24% | -5.63% |
| Total Debt Issued | -88.89% | -- | -- | -- | -- |
| Total Debt Repaid | 99.70% | -3,413.37% | -1,377.87% | 0.00% | -2.52% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 59.89% | -452.31% | 87.43% | -237.91% | 92.15% |
| Cash from Financing | 124.94% | -901.34% | -192.33% | -132.36% | -101.19% |
| Foreign Exchange rate Adjustments | 48.00% | -377.78% | 212.50% | 0.00% | -500.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.17% | -633.23% | 428.12% | 42.16% | -109.71% |